» Articles » PMID: 20679525

Closed Headpiece of Integrin αIIbβ3 and Its Complex with an αIIbβ3-specific Antagonist That Does Not Induce Opening

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2010 Aug 4
PMID 20679525
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

The platelet integrin α(IIb)β(3) is essential for hemostasis and thrombosis through its binding of adhesive plasma proteins. We have determined crystal structures of the α(IIb)β(3) headpiece in the absence of ligand and after soaking in RUC-1, a novel small molecule antagonist. In the absence of ligand, the α(IIb)β(3) headpiece is in a closed conformation, distinct from the open conformation visualized in presence of Arg-Gly-Asp (RGD) antagonists. In contrast to RGD antagonists, RUC-1 binds only to the α(IIb) subunit. Molecular dynamics revealed nearly identical binding. Two species-specific residues, α(IIb) Y190 and α(IIb) D232, in the RUC-1 binding site were confirmed as important by mutagenesis. In sharp contrast to RGD-based antagonists, RUC-1 did not induce α(IIb)β(3) to adopt an open conformation, as determined by gel filtration and dynamic light scattering. These studies provide insights into the factors that regulate integrin headpiece opening, and demonstrate the molecular basis for a novel mechanism of integrin antagonism.

Citing Articles

Structural insights into the molecular recognition of integrin αVβ3 by RGD-containing ligands: The role of the specificity-determining loop (SDL).

Mariasoosai C, Bose S, Natesan S bioRxiv. 2024; .

PMID: 39386435 PMC: 11463590. DOI: 10.1101/2024.09.23.614545.


Application of Funnel Metadynamics to the Platelet Integrin αIIbβ3 in Complex with an RGD Peptide.

Coffman R, Bidone T Int J Mol Sci. 2024; 25(12).

PMID: 38928286 PMC: 11203998. DOI: 10.3390/ijms25126580.


Full-length αIIbβ3 cryo-EM structure reveals intact integrin initiate-activation intrinsic architecture.

Huo T, Wu H, Moussa Z, Sen M, Dalton V, Wang Z Structure. 2024; 32(7):899-906.e3.

PMID: 38579706 PMC: 11246237. DOI: 10.1016/j.str.2024.03.006.


Family-wide analysis of integrin structures predicted by AlphaFold2.

Zhang H, Zhu D, Zhu J Comput Struct Biotechnol J. 2023; 21:4497-4507.

PMID: 37753178 PMC: 10518446. DOI: 10.1016/j.csbj.2023.09.022.


Family-wide analysis of integrin structures predicted by AlphaFold2.

Zhang H, Zhu D, Zhu J bioRxiv. 2023; .

PMID: 37205578 PMC: 10187181. DOI: 10.1101/2023.05.02.539023.


References
1.
Kouns W, Kirchhofer D, Hadvary P, Edenhofer A, Weller T, Pfenninger G . Reversible conformational changes induced in glycoprotein IIb-IIIa by a potent and selective peptidomimetic inhibitor. Blood. 1992; 80(10):2539-47. View

2.
Xiong J, Mahalingham B, Alonso J, Borrelli L, Rui X, Anand S . Crystal structure of the complete integrin alphaVbeta3 ectodomain plus an alpha/beta transmembrane fragment. J Cell Biol. 2009; 186(4):589-600. PMC: 2733745. DOI: 10.1083/jcb.200905085. View

3.
Scarborough R, Gretler D . Platelet glycoprotein IIb-IIIa antagonists as prototypical integrin blockers: novel parenteral and potential oral antithrombotic agents. J Med Chem. 2000; 43(19):3453-73. DOI: 10.1021/jm000022w. View

4.
Alghisi G, Ponsonnet L, Ruegg C . The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells. PLoS One. 2009; 4(2):e4449. PMC: 2636874. DOI: 10.1371/journal.pone.0004449. View

5.
Coller B, Peerschke E, Scudder L, Sullivan C . A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest. 1983; 72(1):325-38. PMC: 1129188. DOI: 10.1172/jci110973. View